Developing a new adoptive T cell immunotherapy with AIM’s organ-on-a-chip
This month’s theme: exploring studies to develop T cell immunotherapy, powered by AIM Biotech AIM Biotech’s organ-on-a-chip is a useful tool for preclinical studies. During this month, we’ll showcase how research powered by AIM Biotech’s organ-on-a-chip...
Featured study: Mimicking a tumor in a chip to study new lung cancer therapies
Small cell lung carcinoma:Tackling a resistant cancer AIM Biotech’s organ-on-a-chip has again demonstrated again how its technology allows the simulation of a tumor to study the migration of T cells in a human tumor environment. Mahadevan and coll. studied a possible...
Featured study: modeling the human tumor microenvironment for IL-15 on AIM technology
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy Our applications development manager Lim Sei Hien discusses one recent study in cancer immunotherapy that benefited from the humanized technology in AIM Biotech’s...
The secret to better blood-brain barrier models
Permeability. That’s the core challenge of studying drugs in the blood-brain barrier. Blood vessels inside the human brain include complex layers of endothelia, pericytes, astrocyes and more insulating their contents from all that grey matter—and for good reason, of...